Regulation of interleukin-8 expression by tumor-associated stress factors

Journal of Interferon and Cytokine Research

Volumn 21, Issue 8, 2001, Pages 553-566

  Shi, Q ^a   Xiong, Q ^a   Le, X ^a   Xie, K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CYTOKINE; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PACLITAXEL; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ACIDOSIS; ANGIOGENESIS; ANOXIA; BINDING SITE; CANCER GROWTH; CELL DENSITY; HUMAN; HYPERGLYCEMIA; HYPERTHERMIA; HYPOXIA; METASTASIS; MITOGENESIS; NONHUMAN; OSMOTIC PRESSURE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION; REVIEW; STRESS; TUMOR GROWTH;

ANIMALS; HUMANS; INTERLEUKIN-8; NEOPLASMS; STRESS;

EID: 0034809005     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/10799900152547812     Document Type: Review

References (191)

1. Expression and secretion of leukocyte chemotactic cytokines by normal human melanocytes and melanoma cells
2. Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: Results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia
3. Cytokine gene expression in B-cell chronic lymphocytic leukemia: Evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein
4. Induction and regulation of IL-8 and MCAF production in human brain tumor cell lines and brain tumor tissues
5. Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: Identification of interleukin-8 as a potential regulatory factor in breast tumors
6. The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours
7. Characterization of GRO alpha, beta and gamma expression in human colonic tumours: Potential significance of cytokine involvement
8. Interleukin-8 has antitumor effects in the rat which are not associated with polymorphonuclear leukocyte cytotoxicity
9. Interleukin-8 as a growth factor for human colorectal carcinoma cells in vitro
10. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro
11. Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer
12. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene
13. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas
14. Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice
15. In vitro differentiation of a Hodgkin's disease derived cell line
16. Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells
17. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma
18. Spontaneous production of interleukin-8 by human lung cancer cells and its augmentation by tumor necrosis factor alpha and interleukin-1 at protein and mRNA levels
19. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer
20. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice
21. Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung
22. The angiogenic factor interleukin 8 is induced in non-small cell lung cancer/pulmonary fibroblast co-cultures
23. Paclitaxel upregulates interleukin-8 synthesis in human lung carcinoma through an NF-kappaB- and AP-1-dependent mechanism
24. Expression of cytokine genes, including IL-6, in human malignant melanoma cell lines
25. Production of multiple cytokines by cultured human melanomas
26. Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells
27. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes
28. Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumour load
29. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor
30. Angiogenesis in mesotheliomas. Role of mesothelial cell-derived IL-8
31. Growth-stimulating activity of interleukin 6 on human mammary epithelial cells transfected with the int-2 gene
32. Regulation of interleukin-8 gene expression by all-trans retinoic acid
33. An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines
34. Cytokine level in malignant ascites and peripheral blood of patients with advanced ovarian carcinoma
35. Tumor-host interaction: Analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas
36. The chemotactic cytokine interleukin-8 - A cyst fluid marker for malignant epithelial ovarian cancer?
37. Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer
38. Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promoter
39. Identification of the structural region of Taxol that may be responsible for cytokine gene induction and cytotoxicity in human ovarian cancer cells
40. Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: Analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype
41. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice
42. Angiogenic activity and interleukin-8 content of human ovarian cancer ascites
43. IL-8 reduced tumorigenicity of human ovarian cancer in vivo due to neutrophil infiltration
44. IL-8 mRNA expression by in situ hybridisation in human pituitary adenomas
45. Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6
46. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique
47. Angiogenesis and prostate cancer: In vivo and in vitro expression of angiogenesis factors by prostate cancer cells
48. Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer
49. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor
50. CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor
51. Endothelium-derived factors as paracrine mediators of prostate cancer progression
52. The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinoma
53. Neutrophil chemotactic factors produced by a cell line from thyroid carcinoma
54. Thyroid follicular cells produce interleukin-8
55. Constitutive and inducible interleukin-8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic
56. Regulation of interleukin-8 expression by cellular pH in human pancreatic adenocarcinoma cells
57. Cooperation between transcription factor AP-1 and NF-κB in the induction of interleukin-8 in human pancreatic adenocarcinoma cells by hypoxia
58. Molecular regulation of constitutive expression of interleukin-8 in human pancreatic adenocarcinoma
59. Neutrophil attractant/activation protein-1 (NAP-1) causes human basophil histamine release
60. Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3
61. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes
62. Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions
63. Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8
64. Interleukin-8 stimulates the migration of human colonic epithelial cells in vitro
65. The role of hyaluronan and interleukin 8 in the migration of chronic lymphocytic leukemia cells within lymphoreticular tissues
66. (+) cells and their transmigration through reconstituted basement membrane
67. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis
68. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice
69. Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells
70. Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells
71. Interleukin 8: An autocrine growth factor for malignant mesothelioma
72. Interleukin-8 as a macrophage-derived mediator of angiogenesis
73. Interleukin-8 and tumor necrosis factor-alpha are involved in human aortic endothelial cell migration. The possible role of these cytokines in human aortic aneurysmal blood vessel growth
74. Interleukin-8 stimulates angiogenesis in rats
75. Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress
76. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis
77. In vitro and in vivo systems to assess role of C-X-C chemokines in regulation of angiogenesis
78. Macrophages and angiogenesis
79. The role of cytokines in cancer
80. Mast cells and de novo angiogenesis: Angiogenic capability of individual mast cell mediators such as histamine, TNF, IL-8 and bFGF
81. Interleukin-1-alpha and de novo mammalian angiogenesis
82. Dual pathways of tubular morphogenesis of vascular endothelial cells by human glioma cells: Vascular endothelial growth factor/basic fibroblast growth factor and interleukin-8
83. Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma
84. Role of angiogenic factors: Coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma
85. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer
86. Expression of multiple angiogenic cytokines in cultured normal human prostate epithelial cells: Predominance of vascular endothelial growth factor
87. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer
88. Angiogenesis in normal tissue adjacent to colon cancer
89. Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue
90. Blockade of NF-κB signalling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin-8
91. High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata
92. Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers
93. Angiogenic balance in human melanoma: Expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo
94. Expression of interleukin-8 detected byin situ hybridization correlates with worse prognosis in primary cutaneous melanoma
95. Expression of interleukin-8 in primary and metastatic malignant melanoma of the skin
96. Interleukin-8 antitumour effect is associated with a local infiltration but not with a systemic activation of T lymphocytes
97. Interleukin 8 and MCAF: Novel inflammatory cytokines inducible by IL 1 and TNF
98. Interleukin-8: A review
99. Molecular mechanism of interleukin-8 gene expression
100. Interleukin-8 and the chemokine family
101. Regulation of interleukin-8 gene expression
102. Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes
103. Growth dependency of a new human pancreatic cancer cell line, YAPC, on autocrine interleukin-1 alpha stimulation
104. Nitric oxide as a secretory product of mammalian cells
105. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression
106. The multifaceted roles of nitric oxide in cancer
107. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase
108. Inflammation, immunoregulation, and inducible nitric oxide synthase
109. Role of nitric oxide in tumor progression: Lessons from experimental tumors
110. Regulation of cytokine gene expression by reactive oxygen and reactive nitrogen intermediates
111. Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level
112. Upregulation of interleukin-1beta-stimulated interleukin-8 in human keratinocytes by nitric oxide
113. Nitric oxide regulates interleukin-8 gene expression in activated endothelium by inhibiting NF-kappaB binding to DNA: Effects of endothelial function
114. Nitric oxide mediated modulation of interleukin-8 production by a human glioblastoma cell line, T98G, cocultured with myeloid and monocytic cell lines
115. Tumor angiogenesis and tissue factor
116. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review
117. 2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation
118. Treatment of cancer with radiation and drugs
119. Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis
120. Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma
121. Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness
122. Hypoxic induction of interleukin-8 gene expression in human endothelial cells
123. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo
124. Low environmental pH is responsible for the induction of nitric oxide synthase in macrophages. Evidence for involvement of nuclear factor-kappaB activation
125. Vascular endothelial growth factor and retinal neovascularisation: A new therapeutic approach for diabetic retinopathy
126. Haemorrhagic shock and encephalopathy syndrome: Report of two cases with special reference to hypoglycaemia
127. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
128. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT
129. Osmotic regulation of cytokine synthesis in vitro
130. Hyperosmotic stress as a stimulant for proinflammatory cytokine production
131. Evolution of oxmotic stress signaling via MAP kinase cascades
132. Interleukin-8 primes human neutrophils for enhanced superoxide anion production
133. Anti-interleukin-8 monoclonal antibody reduces free radical production and improves hemodynamics and survival rate in endotoxic shock in rabbits
134. Regulation of interleukin 8 gene expression by oxidant stress
135. Cadmium induces interleukin-8 production in human peripheral blood mononuclear cells with the concomitant generation of superoxide radicals
136. Toxic metals stimulate inflammatory cytokines in hepatocytes through oxidative stress mechanisms
137. Environmental particulate-mediated cytokine production in lung epithelial cells (A549): Role of preexisting inflammation and oxidant stress
138. Asbestos induces inflammatory cytokines in the lung through redox sensitive transcription factors
139. Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-kappaB activation and IL-8 mRNA expression in guinea pigs in vivo
140. The role of oxidative stress in rhinovirus-induced elaboration of IL-8 by respiratory epithelial cells
141. Alpha particles induce the production of interleukin-8 by human cells
142. Evidence for involvement of the epidermal platelet-activating factor receptor in ultraviolet-B-radiation-induced interleukin-8 production
143. Peroxynitrite mediates IL-8 gene expression and production in lipopolysaccharide-stimulated human whole blood
144. Redox regulation of interleukin-8 expression in MKN28 cells
145. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: Differential activation and binding of the transcription factors AP-1 and NF-kappaB
146. 2 and tumor necrosis factor-alpha induce differential binding of the redox-responsive transcription factors AP-1 and NF-kappaB to the interleukin-8 promoter in endothelial and epithelial cells
147. Enhanced AP-1 and NF-kappaB activities and stability of interleukin 8 (IL-8) transcripts are implicated in IL-8 mRNA superinduction in lung epithelial H292 cells
148. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B
149. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression
150. Oct-1 and CCAAT/enhancer-binding protein (C/EBP) bind to overlapping elements within the interleukin-8 promoter. The role of Oct-1 as a transcriptional repressor
151. Hyperthermic treatment of malignant diseases: Current status and a view toward the future
152. In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C
153. Thermal sensitivity of endothelial cells
154. Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: The effect of anti-inflammatory agents
155. Interleukin-8 induces fever by a prostaglandin-independent mechanism
156. Multiple mechanisms mediate antipyretic action of glucocorticoids
157. Cytokine induction by 41.8 degrees C whole body hyperthermia
158. Whole body hyperthermia cytokine induction: A review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapy
159. Effects of hyperthermia and tumour necrosis factor on inflammatory cytokine secretion and procoagulant activity in endothelial cells
160. Survival of human epidermal keratinocytes after short-duration high temperature: Synthesis of HSP70 and IL-8
161. Local hyperthermia abrogates the anti-immunotherapeutic effect of interleukin-8
162. The release of a neutrophil chemotactic factor from UV-B irradiated rabbit corneas in vitro
163. IL-8 gene expression and production in human keratinocytes and their modulation by UVB
164. Interleukin-8 and melanoma growth-stimulating activity (GRO) are induced by ultraviolet B radiation in human keratinocyte cell lines
165. UVA1 and UVB radiation but not PGE2 stimulate IL-8 release in normal human keratinocytes
166. Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8
167. Ultraviolet light and interleukin-10 modulate expression of cytokines by transformed human dermal microvascular endothelial cells (HMEC-1)
168. Granulocyte/macrophage colony-stimulating factor is an intrinsic keratinocyte-derived growth factor for human melanocytes in UVA-induced melanosis
169. Induction of proinflammatory cytokines in human epidermoid carcinoma cells byin vitro ultraviolet A1 irradiation
170. Effects of UV irradiation with one minimal erythema dose on human afferent skin lymph in vivo
171. Low-energy helium-neon laser irradiation stimulates interleukin-1 alpha and interleukin-8 release from cultured humankeratinocytes
172. Differential regulation by IL-4 and IL-10 of radiation-induced IL-6 and IL-8 production and ICAM-1 expression by human endothelial cells
173. AP-1: One switch for many signals
174. Radiation-induced signal transduction. Mechanisms and consequences
175. Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer
176. Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promoter
177. Paclitaxel (Taxol)-induced gene expression and cell death are both mediated by the activation of c-Jun NH2-terminal kinase (JNK/SAPK)
178. Production of IL-8 by the THP-1 monocyte cell line is regulated differently by cyclosporin and retinoic acid
179. - Helicobacter pylori
180. Activation of MAPKs in human bronchial epithelial cells exposed to metals
181. Extracellular signal-regulated kinase 1/extracellular signal-regulated kinase 2 mitogen-activated protein kinase signaling and activation of activator protein 1 and nuclear factor kappaB transcription factors play central roles in interleukin-8 expression stimulated by monosodium urate monohydrate and calcium pyrophosphate crystals in monocytic cells
182. Stress-activated protein kinase/Jun N-terminal kinase is required for interleukin (IL)-1-induced IL-6 and IL-8 gene expression in the human epidermal carcinoma cell line KB
183. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1
184. H. pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells
185. A conserved AU sequence from the 39 untranslated region of GM-CSF mRNA mediates selective mRNA degradation
186. AU-rich elements: Characterization and importance in mRNA degradation
187. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism
188. Hydrogen peroxide induces tumor necrosis factor alpha-mediated cardiac injury by a p38 mitogen-activated protein kinase-dependent mechanism
189. Activation of JNK, p38 and ERK mitigen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity
190. Hypoxia and hypoxia/reoxygenation activate p65PAK, p38 mitogen-activated protein kinase (MAPK), and stress-activated protein kinase (SAPK) in cultured rat cardiac myocytes
191. Hyperosmolality causes growth arrest of murine kidney cells. Induction of GADD45 and GADD153 by osmosensing via stress-activated protein kinase 2